儿童及青少年分化型甲状腺癌远处转移:临床结局与危险因素分析
回顾性分析171例19岁以下分化型甲状腺癌患者,29例出现远处转移且均为肺转移。肺转移形态分三类,无 apparent 结节者完全缓解率最高。性别、临床淋巴结转移、甲状腺外侵犯和淋巴结转移数目与无远处转移生存显著相关,低、中、高危组20年无远处转移生存率分别为99.0%、71.7%和28.6%。
要点
- 29例远处转移均为肺转移,形态分大结节、小结节和无 apparent 结节三型。
- 无 apparent 结节者按ATA标准达极好反应或按RECIST达完全缓解者最多。
- 低、中、高危组20年无远处转移生存率分别为99.0%、71.7%、28.6%。
核心结论
- 为实现放射性碘治疗的充分疗效,宜在明显转移灶出现前早期诊断远处转移。
- 对儿童及青少年分化型甲状腺癌,选择性治疗策略更为可取。
研究设计与样本
- 回顾性分析1979年至2014年间接受初次手术的171例19岁以下分化型甲状腺癌患者的病历资料。
主要发现
- 29例患者观察到远处转移,且均为肺转移。
- 肺转移形态分为大结节型、小结节型和无 apparent 结节型(仅由放射性碘闪烁显像发现)。
- 按ATA成人分化型甲状腺癌指南标准达极好反应或按RECIST标准达完全缓解者,最常见于无 apparent 结节型患者。
- 与无远处转移生存显著相关的因素为性别、临床淋巴结转移、甲状腺外侵犯和淋巴结转移数目。
- 低危组(无危险因素)、中危组(1个危险因素)和高危组(≥2个危险因素)的20年无远处转移生存率分别为99.0%、71.7%和28.6%。
关键数值与推荐
- 按危险因素数目分组:低危为无危险因素,中危为1个危险因素,高危为≥2个危险因素。
- 低危组20年无远处转移生存率为99.0%,中危组为71.7%,高危组为28.6%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The specific characteristics of pediatric and adolescent differentiated thyroid cancer (DTC) is the more frequent occurrence of distant metastasis (DM) compared with adult DTC. OBJECTIVE: To investigate the clinical outcomes of DM in this population and analyze risk factors related to DM. DESIGN, SETTING, AND PARTICIPANTS: Medical records of 171 patients with DTC < 19 years old, who underwent initial surgery between 1979 and 2014 were retrospectively reviewed. MAIN OUTCOME MEASURE: Clinical responses to radioiodine (RAI) therapy evaluated by the American Thyroid Association (ATA) guidelines for adult DTC and Response Evaluation Criteria in Solid Tumors (RECIST) criteria. Risk factors related to distant-metastasis-free survival (DMFS). RESULTS: DM was observed in 29 patients, and all were lung metastases. The pattern of lung metastasis was classified into 3 categories: macronodular, micronodular, and no apparent nodule (detected only by RAI scintigraphy). Patients with excellent responses according to the ATA guideline criteria or complete remission of the RECIST criteria were most frequently observed in those with no apparent nodule. Significant factors related to DMFS were sex, clinical lymph node metastasis (LNM), extrathyroidal extension, and number of LNM. Subjects were divided into 3 groups according to the number of risk factors: low risk (no risk factors); intermediate risk (1 risk factor); and high risk (≥2 risk factors). Twenty-year DMFS rates in the low-, intermediate-, and high-risk groups were 99.0%, 71.7%, and 28.6%, respectively. CONCLUSION: To achieve the full efficacy of RAI therapy, early diagnosis of DM before apparent metastases appear is desirable. The selective approach would be preferable for pediatric and adolescent DTC.
引用
- Sugino K, Nagahama M, Kitagawa W, et al. Distant Metastasis in Pediatric and Adolescent Differentiated Thyroid Cancer: Clinical Outcomes and Risk Factor Analyses. J Clin Endocrinol Metab. 2020. PMID: 32813019. doi:10.1210/clinem/dgaa545
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。